{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:35:31Z","timestamp":1770348931345,"version":"3.49.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0165942","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T19:05:00Z","timestamp":1479236700000},"page":"e0165942","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Jirui","family":"Bi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cijiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"issue":"Suppl 2","key":"ref1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/cc4927","article-title":"Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database","volume":"10","author":"M Woodhead","year":"2006","journal-title":"Crit Care"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"MA Said","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMcp1214869","article-title":"Clinical practice. Community-acquired pneumonia","volume":"370","author":"RG Wunderink","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.ccx.0000140949.05643.34","article-title":"Severe community-acquired pneumonia","volume":"10","author":"F Alvarez-Lerma","year":"2004","journal-title":"Curr Opin Crit Care"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock","volume":"35","author":"A Rodriguez","year":"2007","journal-title":"Crit Care Med"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/00325481.2015.1074030","article-title":"Community-acquired pneumonia: An overview","volume":"127","author":"LA Mandell","year":"2015","journal-title":"Postgraduate medicine"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1183\/09031936.00074410","article-title":"Systemic cytokine response in patients with community-acquired pneumonia","volume":"37","author":"H Endeman","year":"2011","journal-title":"The European respiratory journal"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1183\/09031936.00040710","article-title":"Factors associated with inflammatory cytokine patterns in community-acquired pneumonia","volume":"37","author":"R Martinez","year":"2011","journal-title":"The European respiratory journal"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1465-9921-15-27","article-title":"Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis","volume":"15","author":"S Aliberti","year":"2014","journal-title":"Respiratory research"},{"issue":"16","key":"ref10","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"T Rhen","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine","volume":"36","author":"PE Marik","year":"2008","journal-title":"Crit Care Med"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00134-005-0046-9","article-title":"Cortisol levels in patients with severe community-acquired pneumonia","volume":"32","author":"JI Salluh","year":"2006","journal-title":"Intensive Care Med"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.08-1382","article-title":"Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity","volume":"134","author":"JI Salluh","year":"2008","journal-title":"Chest"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1183\/09031936.00081514","article-title":"Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients","volume":"45","author":"T Tagami","year":"2015","journal-title":"The European respiratory journal"},{"issue":"3","key":"ref15","first-page":"197","article-title":"The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin","volume":"98","author":"HN Wagner Jr.","year":"1956","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"5840","key":"ref16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.4.5840.569","article-title":"Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial","volume":"4","author":"VU McHardy","year":"1972","journal-title":"Br Med J"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1378\/chest.104.2.389","article-title":"Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study","volume":"104","author":"P Marik","year":"1993","journal-title":"Chest"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","volume":"171","author":"M Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","first-page":"91","article-title":"Effects of low-dose hydrocortisone in ICU patients with severe community-acquired pneumonia","volume":"55","author":"AH El-Ghamrawy","year":"2006","journal-title":"Egyptian Journal of Chest"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00408-007-9020-3","article-title":"Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization","volume":"185","author":"K Mikami","year":"2007","journal-title":"Lung"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial","volume":"181","author":"D Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc10103","article-title":"Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial","volume":"15","author":"S Fernandez-Serrano","year":"2011","journal-title":"Crit Care"},{"issue":"9782","key":"ref23","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"SC Meijvis","year":"2011","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4236\/pp.2011.22009","article-title":"Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings","volume":"2","author":"NA Sabry","year":"2011","journal-title":"Pharmacol Pharm"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jinf.2012.03.008","article-title":"Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia","volume":"65","author":"HH Remmelts","year":"2012","journal-title":"J Infect"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","article-title":"Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia","volume":"62","author":"RM Nafae","year":"2013","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"issue":"9977","key":"ref27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"CA Blum","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"A Torres","year":"2015","journal-title":"Jama"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jac\/dkn283","article-title":"Adjunctive therapies for community-acquired pneumonia: a systematic review","volume":"62","author":"II Siempos","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jcrc.2010.03.004","article-title":"Cortisol levels and adrenal response in severe community-acquired pneumonia: a systematic review of the literature","volume":"25","author":"JI Salluh","year":"2010","journal-title":"J Crit Care"},{"issue":"3","key":"ref31","first-page":"Cd007720","article-title":"Corticosteroids for pneumonia","author":"Y Chen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"e47926","DOI":"10.1371\/journal.pone.0047926","article-title":"Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis","volume":"7","author":"W Nie","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jhm.1992","article-title":"Adjuvant steroid therapy in community-acquired pneumonia: a systematic review and meta-analysis","volume":"8","author":"M Shafiq","year":"2013","journal-title":"J Hosp Med"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.4187\/respcare.03444","article-title":"Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis","volume":"59","author":"D Gusmao-Flores","year":"2014","journal-title":"Respir Care"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"14061","DOI":"10.1038\/srep14061","article-title":"Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update","volume":"5","author":"N Horita","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/M15-0715","article-title":"Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis","volume":"163","author":"RA Siemieniuk","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1378\/chest.15-1733","article-title":"Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis","volume":"149","author":"YD Wan","year":"2016","journal-title":"Chest"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"WS Lim","year":"2003","journal-title":"Thorax"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"MJ Fine","year":"1997","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"ref40","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"LA Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"ref41","first-page":"Iv1","article-title":"BTS Guidelines for the Management of Community Acquired Pneumonia in Adults","volume":"56","year":"2001","journal-title":"Thorax"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/cc11447","article-title":"Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis","volume":"16","author":"C Marti","year":"2012","journal-title":"Crit Care"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/589754","article-title":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia","volume":"47","author":"PG Charles","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/CCM.0b013e318194b021","article-title":"PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia","volume":"37","author":"J Rello","year":"2009","journal-title":"Crit Care Med"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccc.2013.03.009","article-title":"Severe community-acquired pneumonia","volume":"29","author":"WI Sligl","year":"2013","journal-title":"Crit Care Clin"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"SP Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"7414","key":"ref47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"Bmj"},{"issue":"7304","key":"ref48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"JA Sterne","year":"2001","journal-title":"Bmj"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"Bmj"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s10753-014-9840-2","article-title":"Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia","volume":"37","author":"R Fernandez-Botran","year":"2014","journal-title":"Inflammation"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fj.01-0245com","article-title":"Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells","volume":"16","author":"J Galon","year":"2002","journal-title":"Faseb j"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/09031936.00009208","article-title":"Effects of glucocorticoids in ventilated piglets with severe pneumonia","volume":"32","author":"O Sibila","year":"2008","journal-title":"The European respiratory journal"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jcrc.2009.08.009","article-title":"Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials","volume":"25","author":"F Lamontagne","year":"2010","journal-title":"J Crit Care"},{"issue":"12","key":"ref54","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archinternmed.2012.1690","article-title":"Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial","volume":"172","author":"J Carratala","year":"2012","journal-title":"Arch Intern Med"},{"issue":"22","key":"ref55","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.2009.815","article-title":"Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review","volume":"301","author":"D Annane","year":"2009","journal-title":"Jama"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0165942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T03:30:30Z","timestamp":1540351830000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0165942"}},"subtitle":[],"editor":[{"given":"Cordula M.","family":"Stover","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0165942","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}